BlueCrest Capital Management Ltd - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 8 filers reported holding GLAXOSMITHKLINE PLC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.9%.

Quarter-by-quarter ownership
BlueCrest Capital Management Ltd ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2018$8,524,000
+295.2%
211,462
+313.4%
0.22%
+116.7%
Q1 2017$2,157,000
+330.5%
51,157
+293.5%
0.10%
+277.8%
Q4 2016$501,00013,0000.03%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Sio Capital Management, LLC 325,823$11,557,0006.52%
KAHN BROTHERS GROUP INC 1,139,163$40,406,111,0006.35%
Chubb Ltd 400,000$14,188,0006.18%
Healthcare Value Capital, LLC 50,000$1,774,0005.40%
CLARK ESTATES INC/NY 650,000$23,056,0003.81%
PVG ASSET MANAGEMENT CORP 220,450$7,819,361,0003.57%
Martin Capital Partners, LLC 88,195$3,128,0003.25%
Camber Capital Management LP 1,500,000$53,205,0002.60%
EQUITY INVESTMENT CORP 2,090,120$74,137,0002.47%
Keystone Financial Planning, Inc. 129,102$4,579,0002.44%
View complete list of GLAXOSMITHKLINE PLC shareholders